Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403764![]() ((2S,5R)-1-(3-((4-chlorobenzyl)oxy)-5-methoxybenzoy...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403803![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-isobutylbenzoyl)py...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403806![]() ((2S,5R)-5-(2-chlorophenyl)-1-(3-methoxy-5-(2-metho...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403811![]() ((2S,5R)-5-(2-chlorophenyl)-1-(3-((3,5-dimethylisox...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403816![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-(trifluoromethoxy)...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403831![]() ((2S,5R)-1-(2-([1,1'-biphenyl]-4-yl)acetyl)-5-(2-ch...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403837![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-(pyridin-2-yl)benz...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403841![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-((3,5-dimethylisox...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403854![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-(pyrimidin-5-yl)be...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403866![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4'-methoxy-[1,1'-bip...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403867![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-(4-methoxypyridin-...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403905![]() ((2S,5R)-5-(2-chlorophenyl)-1-(9-methyl-9H-carbazol...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403915![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-(4-chlorophenyl)cy...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403916![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-phenylcyclohexanec...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403936![]() ((2S,5R)-5-(2-chlorophenyl)-1-(2',4'-dichloro-[1,1'...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403941![]() ((2S,5R)-5-(2-chlorophenyl)-1-(2',4'-dimethoxy-[1,1...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403949![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-(2-methylthiophen-...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403968![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-(2,6-dimethoxypyri...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403979![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-(2-(2-methoxyethox...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403980![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-(3-methoxypyrazin-...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403991![]() ((2S,5R)-1-(4-(2,6-dimethoxypyridin-3-yl)benzoyl)-5...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404122![]() ((2S,5R)-5-(2-chlorophenyl)-1-(2',3'-dimethoxy-[1,1...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404124![]() ((2S,5R)-5-(2-chlorophenyl)-1-(3',4'-dimethoxy-[1,1...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404141![]() ((2S,5R)-5-cyclopentyl-1-(2'-methoxy-[1,1'-biphenyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404147![]() ((2S,5R)-1-([1,1':4',1''-terphenyl]-4-carbonyl)-5-(...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404163![]() ((2S,5R)-5-(2-fluorophenyl)-1-(5-methoxy-6-(2-metho...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404181![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-(4,6-dimethoxypyri...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404193![]() ((2S,5R)-5-(2-chlorophenyl)-1-(2',3,6'-trimethoxy-[...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404202![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-(2,6-dimethoxypyri...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404203![]() ((2S,5R)-5-(2-chlorophenyl)-1-(3-fluoro-4-(6-methox...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404204![]() ((2S,5R)-5-(2-chlorophenyl)-1-(1-(2-cyano-4-(triflu...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404216![]() ((2S,5R)-5-(2-chlorophenyl)-1-(1-(2-cyano-4-(methyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404217![]() ((2S,5R)-5-(2-chlorophenyl)-1-(1-(2-cyano-4-methoxy...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404230![]() ((2S,5R)-5-([1,1'-biphenyl]-2-yl)-1-(2'-methoxy-[1,...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404238![]() ((2S,5R)-5-(2-chlorophenyl)-1-(1-(2-methoxy-4-(trif...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM404253![]() ((2S,5R)-5-(2,3-difluorophenyl)-1-(4-(2,4-dimethoxy...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403793![]() ((2S,5R)-5-(2-chlorophenyl)-1-(3,5-dimethoxybenzoyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403804![]() ((2S,5R)-5-(2-chlorophenyl)-1-(2,2-difluorobenzo[d]...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403807![]() ((2S,5R)-5-(2-chlorophenyl)-1-(3'-methoxy-[1,1'-bip...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403810![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-isopropoxybenzoyl)...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403815![]() ((2S,5R)-5-(2-chlorophenyl)-1-(2-phenylpyrimidine-5...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403820![]() ((2S,5R)-1-([1,1'-biphenyl]-4-carbonyl)-5-(3-chloro...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403826![]() ((2S,5S)-5-(2-chlorophenyl)-1-(3-methoxybenzoyl)pyr...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403839![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-((4-methoxyphenoxy...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403849![]() ((2S,5R)-5-(2-chlorophenyl)-1-(4-(5-oxo-3-phenyl-4,...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403882![]() ((2S,5R)-5-(2-chlorophenyl)-1-(3',5'-difluoro-[1,1'...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403904![]() ((2S,5R)-5-(2-chlorophenyl)-1-(2'-(methylsulfonyl)-...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403907![]() ((2S,5R)-1-(4-benzylbenzoyl)-5-(2-chlorophenyl)pyrr...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403917![]() (((2R,5S)-2-(2-chlorophenyl)-5-(1H-tetrazol-5-yl)py...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM403933![]() ((2S,5R)-5-(2-chlorophenyl)-1-(2',6'-dimethoxy-[1,1...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <200 | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co... | US Patent US10017468 (2018) BindingDB Entry DOI: 10.7270/Q2HM5BST | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 277 total ) | Next | Last >> |